Medicine
Paroxetine 30 mg tablet
Paroxetine 30 mg tablet is a generic prescription medicine for oral use, made by 21 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25°C (68°F to 77°F).
Key facts
- Active ingredient (INN)
- Paroxetine
- Brand
- Sold under the generic name
- Strength
- 30 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 500 tablets, 30 tablets and 73 more
- Manufacturers
- Zydus LifesciencesIndiaAurobindo PharmaIndiaAurolife PharmaIndiaOxford PharmaceuticalsYiling PharmaceuticalSolco HealthcareApotexMylan PharmaceuticalsChartwell RX21 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25°C (68°F to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N06AB05 Paroxetine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 30 July 2003
- Identifiers
- RxCUI 1738483, 1738495, 1738503 +1DailyMed set ID b5a8f864-a53d-48d9-aca6-6b64017fb168, ee38b589-e646-4203-bea5-cc3744fe17c3, 679e4b9b-0f7b-450a-aca7-1b448cccbeed +23NDC 68084-046, 68788-7410, 70518-2465 +23Application ANDA077584, ANDA203854, ANDA211248 +4
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 21 labelers. The register lists 76 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet, film coated in 1 bottle | 65841-099-01 | Zydus LifesciencesIndia | 13 April 2007 |
| 500 tablet, film coated in 1 bottle | 65841-099-05 | Zydus LifesciencesIndia | 13 April 2007 |
| 30 tablet, film coated in 1 bottle | 65841-099-06 | Zydus LifesciencesIndia | 13 April 2007 |
| 1000 tablet, film coated in 1 bottle | 65841-099-10 | Zydus LifesciencesIndia | 13 April 2007 |
| 90 tablet, film coated in 1 bottle | 65841-099-16 | Zydus LifesciencesIndia | 13 April 2007 |
| 100 tablet, film coated in 1 bottle | 68382-099-01 | Zydus LifesciencesIndia | 13 April 2007 |
| 500 tablet, film coated in 1 bottle | 68382-099-05 | Zydus LifesciencesIndia | 13 April 2007 |
| 30 tablet, film coated in 1 bottle | 68382-099-06 | Zydus LifesciencesIndia | 13 April 2007 |
| 1000 tablet, film coated in 1 bottle | 68382-099-10 | Zydus LifesciencesIndia | 13 April 2007 |
| 90 tablet, film coated in 1 bottle | 68382-099-16 | Zydus LifesciencesIndia | 13 April 2007 |
| 100 tablet, film coated in 1 bottle | 65862-156-01 | Aurobindo PharmaIndia | 25 July 2007 |
| 500 tablet, film coated in 1 bottle | 65862-156-05 | Aurobindo PharmaIndia | 25 July 2007 |
| 30 tablet, film coated in 1 bottle | 65862-156-30 | Aurobindo PharmaIndia | 25 July 2007 |
| 90 tablet, film coated in 1 bottle | 65862-156-90 | Aurobindo PharmaIndia | 25 July 2007 |
| 1000 tablet, film coated in 1 bottle | 65862-156-99 | Aurobindo PharmaIndia | 25 July 2007 |
| 100 tablet, film coated in 1 bottle | 13107-156-01 | Aurolife PharmaIndia | 3 December 2009 |
| 500 tablet, film coated in 1 bottle | 13107-156-05 | Aurolife PharmaIndia | 3 December 2009 |
| 30 tablet, film coated in 1 bottle | 13107-156-30 | Aurolife PharmaIndia | 3 December 2009 |
| 90 tablet, film coated in 1 bottle | 13107-156-90 | Aurolife PharmaIndia | 3 December 2009 |
| 1000 tablet, film coated in 1 bottle | 13107-156-99 | Aurolife PharmaIndia | 3 December 2009 |
| 30 tablet, film coated in 1 bottle | 60505-0084-1 | Apotex | 8 September 2003 |
| 100 tablet, film coated in 1 bottle | 60505-0084-2 | Apotex | 8 September 2003 |
| 1000 tablet, film coated in 1 bottle | 60505-0084-4 | Apotex | 8 September 2003 |
| 90 tablet, film coated in 1 bottle | 62135-543-90 | Chartwell RX | 11 April 2023 |
| 1000 tablet, film coated in 1 bottle, plastic | 0378-7003-10 | Mylan Pharmaceuticals | 24 March 2008 |
| 30 tablet, film coated in 1 bottle, plastic | 0378-7003-93 | Mylan Pharmaceuticals | 24 March 2008 |
| 30 tablet, film coated in 1 bottle | 69584-673-03 | Oxford Pharmaceuticals | 14 November 2022 |
| 90 tablet, film coated in 1 bottle | 69584-673-09 | Oxford Pharmaceuticals | 14 November 2022 |
| 100 tablet, film coated in 1 bottle | 69584-673-10 | Oxford Pharmaceuticals | 14 November 2022 |
| 500 tablet, film coated in 1 bottle | 69584-673-50 | Oxford Pharmaceuticals | 14 November 2022 |
| 1000 tablet, film coated in 1 bottle | 69584-673-90 | Oxford Pharmaceuticals | 14 November 2022 |
| 30 tablet, film coated in 1 bottle | 43547-349-03 | Solco Healthcare | 29 March 2022 |
| 90 tablet, film coated in 1 bottle | 43547-349-09 | Solco Healthcare | 29 March 2022 |
| 1000 tablet, film coated in 1 bottle | 43547-349-11 | Solco Healthcare | 29 March 2022 |
| 500 tablet, film coated in 1 bottle | 43547-349-50 | Solco Healthcare | 29 March 2022 |
| 30 tablet, film coated in 1 bottle, plastic | 69117-0026-1 | Yiling Pharmaceutical | 2 November 2021 |
| 90 tablet, film coated in 1 bottle, plastic | 69117-0026-2 | Yiling Pharmaceutical | 2 November 2021 |
| 100 tablet, film coated in 1 bottle, plastic | 69117-0026-3 | Yiling Pharmaceutical | 2 November 2021 |
| 500 tablet, film coated in 1 bottle, plastic | 69117-0026-4 | Yiling Pharmaceutical | 2 November 2021 |
| 1000 tablet, film coated in 1 bottle, plastic | 69117-0026-5 | Yiling Pharmaceutical | 2 November 2021 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 29 December 1992 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Paroxetine 30 mg tablet.
Other strengths and forms of Paroxetine
Clinical summary
Paroxetine is a serotonin reuptake inhibitor. It is available as tablets, extended-release tablets and capsules for oral use. MedsAcross supplies Paroxetine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about ParoxetineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- PAXIL prescribing information (Apotex) · U.S. National Library of Medicine, DailyMed
Need Paroxetine 30 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.